AR066725A1 - Prediccion del pronostico para melanoma de cancer - Google Patents
Prediccion del pronostico para melanoma de cancerInfo
- Publication number
- AR066725A1 AR066725A1 ARP080102210A ARP080102210A AR066725A1 AR 066725 A1 AR066725 A1 AR 066725A1 AR P080102210 A ARP080102210 A AR P080102210A AR P080102210 A ARP080102210 A AR P080102210A AR 066725 A1 AR066725 A1 AR 066725A1
- Authority
- AR
- Argentina
- Prior art keywords
- melanoma
- markers
- cancer
- prognostic
- genetic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Data Mining & Analysis (AREA)
- Biomedical Technology (AREA)
- Databases & Information Systems (AREA)
- Primary Health Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Marcadores de pronostico, ôfirmasö genéticas (signatura) de pronostico y composiciones y procedimientos para determinar la prognosis de cáncer en un paciente, particularmente para melanoma. Uso de marcadores genéticos y de proteína para la prediccion del riesgo de progresion de un cáncer, tal como melanoma, basado en marcadores y ôfirmasö genéticas que comprenden tales marcadores. Procedimientos, composiciones, kits y dispositivos basados en tales marcadores de pronostico de cáncer, específicamente marcadores de pronostico de melanoma, (MPMs).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ555363A NZ555363A (en) | 2007-05-24 | 2007-05-24 | Prognosis prediction for melanoma cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
AR066725A1 true AR066725A1 (es) | 2009-09-09 |
Family
ID=40032133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080102210A AR066725A1 (es) | 2007-05-24 | 2008-05-26 | Prediccion del pronostico para melanoma de cancer |
Country Status (17)
Country | Link |
---|---|
US (3) | US8822149B2 (es) |
EP (2) | EP2158332B1 (es) |
JP (5) | JP5943315B2 (es) |
CN (1) | CN101743327B (es) |
AR (1) | AR066725A1 (es) |
AU (1) | AU2008253836B2 (es) |
CA (1) | CA2725602A1 (es) |
CL (1) | CL2008001517A1 (es) |
DK (2) | DK3176270T3 (es) |
ES (2) | ES2622858T3 (es) |
HK (1) | HK1145342A1 (es) |
NZ (1) | NZ555363A (es) |
PT (2) | PT3176270T (es) |
SG (2) | SG10201912289SA (es) |
TW (2) | TWI582236B (es) |
UY (1) | UY31105A1 (es) |
WO (1) | WO2008143533A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120135415A1 (en) * | 2002-11-15 | 2012-05-31 | Morehouse School Of Medicine | Detecting cancer with anti-cxcl13 and anti-cxcr5 antibodies |
CN107102142A (zh) | 2007-03-27 | 2017-08-29 | 伊缪诺维亚公司 | 检测腺癌的蛋白标志/标记 |
JP5683280B2 (ja) * | 2011-01-04 | 2015-03-11 | 株式会社日立製作所 | 診療支援システム |
CN102617734B (zh) * | 2011-12-28 | 2013-09-04 | 暨南大学 | 抗FGF-2抗体Dab-2及其应用 |
US9336302B1 (en) | 2012-07-20 | 2016-05-10 | Zuci Realty Llc | Insight and algorithmic clustering for automated synthesis |
US9355105B2 (en) * | 2012-12-19 | 2016-05-31 | International Business Machines Corporation | Indexing of large scale patient set |
US20140271545A1 (en) | 2013-03-14 | 2014-09-18 | Castle Biosciences, Inc. | Methods for predicting risk of metastasis in cutaneous melanoma |
WO2016177722A1 (en) * | 2015-05-05 | 2016-11-10 | Medizinische Universität Wien | Computerized device and method for processing image data |
WO2018009887A1 (en) * | 2016-07-08 | 2018-01-11 | University Of Hawaii | Joint analysis of multiple high-dimensional data using sparse matrix approximations of rank-1 |
US11205103B2 (en) | 2016-12-09 | 2021-12-21 | The Research Foundation for the State University | Semisupervised autoencoder for sentiment analysis |
US10692605B2 (en) * | 2018-01-08 | 2020-06-23 | International Business Machines Corporation | Library screening for cancer probability |
TW202018727A (zh) | 2018-11-09 | 2020-05-16 | 財團法人工業技術研究院 | 整體式學習預測方法與系統 |
CA3128973A1 (en) | 2019-03-04 | 2020-09-10 | Bhaskar Bhattacharyya | Data compression and communication using machine learning |
GB202010970D0 (en) | 2020-07-16 | 2020-09-02 | Immunovia Ab | Methods, arrays and uses thereof |
CN112200391B (zh) * | 2020-11-17 | 2023-07-04 | 国网陕西省电力公司经济技术研究院 | 基于k-近邻互信息特征简化的配电网边缘侧负荷预测方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101302627B1 (ko) | 2005-01-05 | 2013-09-10 | 아비에 인코포레이티드 | 11-베타-하이드록시스테로이드 데하이드로게나제 타입 1 효소의 억제제 |
AU2006203830A1 (en) * | 2005-01-07 | 2006-07-13 | The Johins Hopkins University | Biomarkers for melanoma |
US7615349B2 (en) * | 2006-09-07 | 2009-11-10 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Melanoma gene signature |
WO2008043018A1 (en) * | 2006-10-04 | 2008-04-10 | Dana-Farber Cancer Institute, Inc. | Tumor immunity |
-
2007
- 2007-05-24 NZ NZ555363A patent/NZ555363A/en unknown
-
2008
- 2008-05-23 PT PT162033013T patent/PT3176270T/pt unknown
- 2008-05-23 CN CN2008800248635A patent/CN101743327B/zh not_active Expired - Fee Related
- 2008-05-23 AU AU2008253836A patent/AU2008253836B2/en not_active Ceased
- 2008-05-23 DK DK16203301.3T patent/DK3176270T3/da active
- 2008-05-23 EP EP08766967.7A patent/EP2158332B1/en active Active
- 2008-05-23 EP EP16203301.3A patent/EP3176270B1/en active Active
- 2008-05-23 DK DK08766967.7T patent/DK2158332T3/en active
- 2008-05-23 PT PT87669677T patent/PT2158332T/pt unknown
- 2008-05-23 CA CA2725602A patent/CA2725602A1/en not_active Abandoned
- 2008-05-23 JP JP2010509293A patent/JP5943315B2/ja not_active Expired - Fee Related
- 2008-05-23 SG SG10201912289SA patent/SG10201912289SA/en unknown
- 2008-05-23 ES ES08766967.7T patent/ES2622858T3/es active Active
- 2008-05-23 TW TW097119301A patent/TWI582236B/zh not_active IP Right Cessation
- 2008-05-23 WO PCT/NZ2008/000118 patent/WO2008143533A1/en active Application Filing
- 2008-05-23 ES ES16203301T patent/ES2821300T3/es active Active
- 2008-05-23 SG SG10201509568QA patent/SG10201509568QA/en unknown
- 2008-05-23 TW TW103127682A patent/TWI609967B/zh not_active IP Right Cessation
- 2008-05-23 CL CL2008001517A patent/CL2008001517A1/es unknown
- 2008-05-26 UY UY31105A patent/UY31105A1/es active IP Right Grant
- 2008-05-26 AR ARP080102210A patent/AR066725A1/es active IP Right Grant
-
2009
- 2009-11-23 US US12/592,385 patent/US8822149B2/en active Active
-
2010
- 2010-12-16 HK HK10111778.3A patent/HK1145342A1/xx not_active IP Right Cessation
-
2014
- 2014-08-29 US US14/472,755 patent/US9534258B2/en active Active
- 2014-10-31 JP JP2014223331A patent/JP2015061528A/ja active Pending
-
2016
- 2016-12-14 JP JP2016242254A patent/JP6404304B2/ja not_active Expired - Fee Related
- 2016-12-27 US US15/391,293 patent/US10266902B2/en not_active Expired - Fee Related
-
2018
- 2018-09-12 JP JP2018170779A patent/JP2019004907A/ja active Pending
-
2020
- 2020-06-04 JP JP2020097666A patent/JP2020150949A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR066725A1 (es) | Prediccion del pronostico para melanoma de cancer | |
EP4219765A3 (en) | Prostate cancer prognosis using biomarkers | |
EP2611941A4 (en) | GENESIS OF CANCER DIAGNOSIS AND PROGNOSIS | |
WO2012006447A3 (en) | Gene signatures for cancer prognosis | |
CO7160023A2 (es) | Métodos y aparatos para predecir riesgo de cáncer de próstata y volumen de glándula prostática | |
MX2013005762A (es) | Biomarcadores para la prediccion de la eficacia de una inmunoterapia contra el cancer. | |
WO2010004589A3 (en) | Genetic variants predictive of cancer risk in humans | |
MX340453B (es) | Biomarcadores para cancer de pulmon. | |
EA201270252A1 (ru) | Консультативные системы и способы бурения с использованием целевых функций | |
BRPI0720371B8 (pt) | métodos para diagnóstico ou monitoramento da progressão de câncer de próstata em um indivíduo e uso in vitro de pelo menos um homeodomínio contendo o fator de transcrição como um biomarcador para câncer de próstata | |
EP2582847A4 (en) | METHOD AND MATERIALS FOR EVALUATING THE LOSS OF HETEROZYGOTY | |
WO2009037572A3 (en) | Biomarker combinations for colorectal cancer | |
ATE509123T1 (de) | Hochauflösende hochdurchsatz-hla-genotypisierung mittels klonaler sequenzierung | |
WO2012061515A3 (en) | Methods of classifying human subjects with regard to cancer prognosis | |
GB0720113D0 (en) | Diagnostic, prognostic and predictive testing for cancer | |
BRPI0907938A2 (pt) | Painel de biomarcadores de carcinoma de pequenas células do pulmão | |
EP4039821A3 (en) | Methods for predicting risk of interstitial pneumonia | |
WO2011112845A3 (en) | Methods and compositions related to a multi-methylation assay to predict patient outcome | |
ATE525484T1 (de) | Slco1b3-genotyp | |
WO2013062261A3 (en) | Newly identified colon cancer marker and diagnostic kit using the same | |
WO2012021714A3 (en) | Biomarker signatures for wellness testing | |
WO2012145607A3 (en) | Specific copy number aberrations as predictors of breast cancer | |
CL2012002762A1 (es) | Método para pronosticar el riesgo de recurrencia de cáncer de próstata en un sujeto, que comprende determinar los niveles de expresión de por lo menos dos marcadores y la probabilidad predictiva en base a un nomograma de kattan; dispositivos; y kit. | |
ES2337973B8 (es) | Adenovirus auxiliares auto-inactivantes para la produccion de adenovirus recombinantes de alta capacidad. | |
WO2012061904A8 (en) | Histone protein ubiquitination as a cancer biomarker |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |